Literature DB >> 21303425

Gene expression of TWEAK/Fn14 and IP-10/CXCR3 in glomerulus and tubulointerstitium of patients with lupus nephritis.

Jianxin Lu1, Bonnie Ching-Ha Kwan, Fernand Mac-Moune Lai, Paul Cheung-Lung Choi, Lai-Shan Tam, Edmund Kwok-Ming Li, Kai-Ming Chow, Gang Wang, Philip Kam-Tao Li, Cheuk-Chun Szeto.   

Abstract

AIM: The role of the tumour necrosis factor-like weak inducer of apoptosis (TWEAK)/Fn14 and interferon-inducible protein (IP-10)/CXCR3 axis in the pathogenesis of lupus nephritis were studied.
METHODS: The mRNA expression of TWEAK, Fn14, IP-10 and CXCR3 were quantified in the glomerulus and tubulointerstitium of 42 patients with lupus nephritis (LN group) and 10 healthy controls.
RESULTS: As compared to controls, LN patients had higher glomerular expression of TWEAK and Fn14, but glomerular CXCR3 expression was lower in the LN group. Similarly, the LN group had higher tubulointerstitial expression of TWEAK and Fn14, but lower tubulointerstitial expression of CXCR3, than controls. Glomerular TWEAK expression of class V nephritis was significantly higher than class IV nephritis. Glomerular expression of CXCR3 significantly correlated with proteinuria (r = -0.532; P = 0.019), whereas tubulointerstitial CXCR3 significantly correlated with serum creatinine (r = -0.447; P = 0.029).
CONCLUSION: In patients with lupus nephritis, there is an increase in intra-renal expression of TWEAK and Fn14, and a decrease in CXCR3 expression. Intra-renal expression of CXCR3 correlates with proteinuria and renal function. Our findings suggest that the TWEAK/Fn14 and IP-10/CXCR3 axis may contribute to the pathogenesis of lupus nephritis.
© 2011 The Authors. Nephrology © 2011 Asian Pacific Society of Nephrology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21303425     DOI: 10.1111/j.1440-1797.2011.01449.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  26 in total

Review 1.  Role of TWEAK in lupus nephritis: a bench-to-bedside review.

Authors:  Jennifer S Michaelson; Nicolas Wisniacki; Linda C Burkly; Chaim Putterman
Journal:  J Autoimmun       Date:  2012-06-22       Impact factor: 7.094

Review 2.  Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis.

Authors:  Zhi-Chun Liu; Qiao-Ling Zhou
Journal:  Inflamm Res       Date:  2012-04       Impact factor: 4.575

3.  Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis.

Authors:  Yumin Xia; Leal C Herlitz; Simona Gindea; Jing Wen; Rahul D Pawar; Alexander Misharin; Harris Perlman; Lan Wu; Ping Wu; Jennifer S Michaelson; Linda C Burkly; Chaim Putterman
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

Review 4.  Biomarkers for kidney involvement in pediatric lupus.

Authors:  Beatrice Goilav; Chaim Putterman; Tamar B Rubinstein
Journal:  Biomark Med       Date:  2015       Impact factor: 2.851

5.  Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14).

Authors:  Andrea Fick; Isabell Lang; Viktoria Schäfer; Axel Seher; Johannes Trebing; Daniela Weisenberger; Harald Wajant
Journal:  J Biol Chem       Date:  2011-11-11       Impact factor: 5.157

Review 6.  Genetics of Lupus Nephritis: Clinical Implications.

Authors:  Melissa E Munroe; Judith A James
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

Review 7.  The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis.

Authors:  Marcus R Clark; Kimberly Trotter; Anthony Chang
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

Review 8.  Role of the TWEAK/Fn14 pathway in autoimmune diseases.

Authors:  Wang-Dong Xu; Yi Zhao; Yi Liu
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

9.  Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus.

Authors:  Chen-Xing Zhang; Li Cai; Kang Shao; Jing Wu; Wei Zhou; Lan-Fang Cao; Tong-Xin Chen
Journal:  Pediatr Nephrol       Date:  2017-12-20       Impact factor: 3.714

10.  Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis.

Authors:  Yumin Xia; Sean R Campbell; Anna Broder; Leal Herlitz; Maria Abadi; Ping Wu; Jennifer S Michaelson; Linda C Burkly; Chaim Putterman
Journal:  Clin Immunol       Date:  2012-08-20       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.